Raveendra et al. [57] identified a panel of peptoids that bind anti-AQP4 antibodies in the serum of NMO patients by using a chemical library screening on beads, an approach that does not limit the screen to a few thousand molecules like in the microarray technology. Here, AQP4 is linked to neuromyelitis optica.